Sign in

CIK 0001720580

  • Non-accelerated filer
  • Smaller reporting company

Adicet Bio, Inc.

Sign in to watch
Ticker
ACET
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 26
Incorporated
DE
Entity type
Operating
EIN
813305277
Phone
+1 617-482-2333
Business address
131 DARTMOUTH STREET, 3RD FLOOR, BOSTON, MA, 02116
Former names
resTORbio, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2019-02-27 MCCABE JOHN J Vice President, Finance Grant or award · Stock Option (Right to Buy) +24,600 24,600
2018-11-05 Schor Chen Director Gift −6,000 325,000
2018-11-05 Grissinger Michael Director Grant or award · Stock Option (Right to Buy) +28,828 28,828
2018-10-26 Mannick Joan Chief Medical Officer Gift −600,000 1,286,363
2018-10-26 Mannick Joan Chief Medical Officer Gift +600,000 600,000
2018-10-15 Schor Chen Director Gift −593,363 356,000
2018-10-15 Schor Chen Director Gift −25,000 331,000
2018-10-15 Schor Chen Director Gift −643,000 943,000
2018-10-15 Schor Chen Director Gift −25,000 943,000
2018-09-17 Manning Meredith Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +175,000 175,000
2018-08-14 Chodakewitz Jeffrey Director Grant or award · Stock Option (Right to Buy) +28,828 28,828
2018-07-06 Schor Chen Director Gift −943,000 949,363
2018-04-16 Schor Chen President and CEO Purchase +2,000 $8.95 $18K 1,892,363
2018-04-11 Schor Chen President and CEO Purchase +2,000 $9.36 $19K 1,890,363
2018-04-10 Schor Chen President and CEO Purchase +2,000 $8.46 $17K 1,888,363
2018-03-13 MCCABE JOHN J Vice President, Finance Grant or award · Stock Option (Right to Buy) +4,603 4,603
2018-01-30 SILVERSTEIN JONATHAN Director Conversion +2,425,485 2,425,485
2018-01-30 SILVERSTEIN JONATHAN Director Conversion +1,871,569 4,297,054
2018-01-30 SILVERSTEIN JONATHAN Director Purchase +533,333 $15.00 $8.0M 4,830,387
2018-01-30 SILVERSTEIN JONATHAN Director Conversion · Series A Preferred Stock −2,425,482 0

Page 28 of 29 · 569 trades